Hims&Hers斥11.5亿美元收购Eucalyptus 加速全球医疗业务布局

Group 1 - Hims & Hers has agreed to acquire digital health company Eucalyptus for $1.15 billion to expand its geographic reach [1] - The transaction involves an upfront payment of $240 million in cash, with the remainder consisting of deferred payments and contingent payments tied to specific financial targets by early 2029 [1] - The acquisition will enable Hims & Hers to enter the Australian and Japanese markets while expanding its existing operations in the UK, Germany, and Canada [1] Group 2 - Hims & Hers plans to enhance its local professional teams and upgrade infrastructure to replicate its successful U.S. model globally, aiming to reach millions of users [1] - The deal is expected to be completed by mid-2026, with Eucalyptus CEO Tim Doyle overseeing Hims & Hers' international business post-acquisition [1] - Hims & Hers is currently facing a lawsuit from Novo Nordisk, which seeks to prohibit the sale of its generic weight loss drugs, alleging patent infringement [2]